Cyrine E. Haidar
- Pharmacology top 0.05%
- Pediatrics, Perinatology and Child Health top 1%
- Genetics top 5%
- Oncology top 10%
- Molecular Biology
- Co-authors
- Teri E. KleinKelly E. CaudleMary V. RellingJames M. HoffmanKristine R. CrewsAndrea GaedigkHenry M. DunnenbergerUlrich Broeckel
- Topics
- Pharmacogenetics and Drug Metabolism (20 papers)Pharmaceutical studies and practices (12 papers)Genomics and Rare Diseases (6 papers)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Cyrine E. Haidar
33 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Pharmacology 1.6k
- Pediatrics, Perinatology and Child Health 948
- Genetics 470
- Oncology 403
- Molecular Biology 371
Countries citing papers authored by Cyrine E. Haidar
This map shows the geographic impact of Cyrine E. Haidar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyrine E. Haidar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyrine E. Haidar more than expected).
Fields of papers citing papers by Cyrine E. Haidar
This network shows the impact of papers produced by Cyrine E. Haidar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyrine E. Haidar. The network helps show where Cyrine E. Haidar may publish in the future.
Co-authorship network of co-authors of Cyrine E. Haidar
This figure shows the co-authorship network connecting the top 25 collaborators of Cyrine E. Haidar. A scholar is included among the top collaborators of Cyrine E. Haidar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cyrine E. Haidar. Cyrine E. Haidar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 9 | |
| 3 | 0 | |
| 4 | 4 | |
| 5 | 23 | |
| 6 | 28 | |
| 7 | 58 | |
| 8 | 10 | |
| 9 | 7 | |
| 10 | 62 | |
| 11 | 56 | |
| 12 | 3 | |
| 13 | 205 | |
| 14 | 92 | |
| 15 | The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Updatebreakdown → | 301 |
| 16 | Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Updatebreakdown → | 453 |
| 17 | 82 | |
| 18 | 159 | |
| 19 | 77 | |
| 20 | 28 |
About Cyrine E. Haidar
Cyrine E. Haidar is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Clinical Biochemistry, having authored 34 papers that have together received 2.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (20 papers), Pharmaceutical studies and practices (12 papers) and Genomics and Rare Diseases (6 papers). The work is most often cited by research in Pharmacology (1.6k citations), Pediatrics, Perinatology and Child Health (948 citations) and Geriatrics and Gerontology (143 citations). Cyrine E. Haidar has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Teri E. Klein, Kelly E. Caudle, Mary V. Relling, James M. Hoffman, Kristine R. Crews, Andrea Gaedigk, Henry M. Dunnenberger, Ulrich Broeckel, Michelle Whirl‐Carrillo and J. Kevin Hicks. Their work appears in journals such as Journal of Clinical Oncology, PEDIATRICS and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.